9Bio Therapeutics selected by Merck Global Health Innovation Fund and CQDM for strategic investment and acceleration program
9Bio Therapeutics is proud to announce a strategic investment from the Merck Global Health Innovation Fund (Merck GHI) and CQDM. The funding will accelerate the development of 9Bio’s computationally guided discovery platform and pipeline of tumor-selective therapies.